Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Trial of the ACTG (Advancing Clinical Therapeutics Globally for HIV and Other Infections)

Study ID: NCT07342491
Start Date: 2026-03-02
End Date: 2027-05-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

14

Intervention / Treatment

Dasatinib

Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Source: clinicaltrials.gov

Share:
Add to list

VibraCool Device to Reduce Pain and Opioid Use After Anterior Cruciate Ligament Reconstruction (ACLR)

Study ID: NCT06456268
Start Date: 2026-06
End Date: 2026-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

130

Intervention / Treatment

VibraCool mechanical stimulation and neuromodulatory therapeutic device

Cryocompression (Game Ready, Bregs) device

Standard ice packs

Sponsor

Columbia University

Source: clinicaltrials.gov

Share:
Add to list

Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

Study ID: NCT07074418
Start Date: 2026-04
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

34

Intervention / Treatment

Empagliflozin 10 MG then Placebo

Placebo then Empagliflozin 10 MG

Sponsor

Nice University Hospital Center

Source: clinicaltrials.gov

Share:
Add to list

Exploratory Study Investigating the Urinary Bladder During Intermittent Catheterization in Healthy and Spinal Cord Injured Male and Female Subjects Using an Upright MRI Scanner

Study ID: NCT07384559
Start Date: 2026-03-02
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

MRI scan

Sponsor

Coloplast A/S

Source: clinicaltrials.gov

Share:
Add to list

Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function

Study ID: NCT05048368
Start Date: 2026-10-30
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Larotinib

Sponsor

Sunshine Lake Pharma Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Effect of Predictive Model on ED Physician Assessments of Patient Disposition

Study ID: NCT06434220
Start Date: 2026-05-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Baseline model

Fairness-aware model

Sponsor

Boston Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)

Study ID: NCT05900388
Start Date: 2026-09-01
End Date: 2029-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

850

Intervention / Treatment

Rivaroxaban (Xarelto, BAY59-7939)

Standard of care (SOC)

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

Study ID: NCT06681220
Start Date: 2026-02-23
End Date: 2030-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

166

Intervention / Treatment

Stenoparib/Temozolomide

Lurbinectedin

Stenoparib/Temozolomide

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)

Study ID: NCT07162480
Start Date: 2026-02-28
End Date: 2031-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

28

Intervention / Treatment

P-Sam

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Digital Interventions for Relapse Prevention in Adolescence

Study ID: NCT07346911
Start Date: 2026-04-07
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

495

Intervention / Treatment

Transdiagnostic app intervention

Transdiagnostic mastery course

Sponsor

University of Oslo

Source: clinicaltrials.gov

Share:
Add to list